Jubilant Pharmova Q1 Results

  • BSE: 530019
  • NSE: JUBLPHARMA
  • ISIN: INE700A01033
  • Sector: Biotechnology & Drugs
BSE
1,113.95-27.25 (-2.39%)
Volume16.94 K
Updated: Mon 25 Nov, 2024 | 15:29:39
NSE
1,113-25.50 (-2.24%)
Volume2.28 L
Updated: Mon 25 Nov, 2024 | 15:29:51
Today: 1,094.10
1,160.80
52-Wk: 408.60
1,309.00

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jubilant Pharmova Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 1,731.701,678.00-%1,586.90-%
    Selling/ General/ Admin Expenses Total 552.90534.30-%547.70-%
    Depreciation/ Amortization 90.70271.23-%89.70-%
    Other Operating Expenses Total 365.60394.71-%349.50-%
    Total Operating Expense 1,175.001,730.01-%1,507.00-%
    Operating Income 556.70-52.01-%79.90-%
    Net Income Before Taxes 499.70-86.41-%25.20-%
    Net Income 482.10-97.84-%6.40-%
    Diluted Normalized EPS 6.34-6.12-%0.40-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts